ConserV Bioscience to develop 'broad-spectrum' coronavirus vaccine
UK biotech company will collaborate with Lawrence Livermore National Laboratory - News - PharmaTimes
Source: pharmatimes.com
Page 3 - Conserv Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Conserv Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Conserv Bioscience Today - Breaking & Trending Today
ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine
Share this article Share this article LONDON, Jan. 19, 2021 /PRNewswire/ -- ConserV Bioscience Limited ("ConserV"), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and Lawrence Livermore National Laboratory ("LLNL") have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine. This collaboration brings together ConserV's expertise in identifying antigens and Lawrence Livermore National Laboratory's nanolipoprotein particle technology ("NLP") delivery system. The vaccine has been desi...
Source: prnewswire.com
LLNL and United Kingdom company to collaborate on development of universal coronavirus vaccine
Date Time LLNL and United Kingdom company to collaborate on development of universal coronavirus vaccine LLNL researchers Nick Fischer and Amy Rasley are characterizing nanolipoprotein particle vaccine formulations using a dynamic light-scattering instrument. Detailed characterization of the nanoparticles provides an important quality control metric for vaccine development. A United Kingdom company, ConserV Bioscience Limited, and LLNL have agreed to work on developing a universal coronavirus vaccine. Photo by Julie Russell/LLNL (taken pre-pandemic). ConserV Bioscience Limited (CBL) and Lawre...
Source: miragenews.com